Semaglutide changes gut bacteria in rats beyond what eating less explains
A controlled feeding experiment in male and female rats investigates whether changes in gut bacteria follow reduced eating…
A New King of The GLP-1s Could Be Crowned – Cardiac Wire
A New King of The GLP-1s Could Be Crowned Cardiac Wire‘Godzilla’ of weight-loss drugs could provide other important health…
Tirzepatide vs semaglutide for asthma: the difference was smaller than researchers expected
Researchers compared two widely used incretin therapies in more than 16,000 matched adults with asthma and type 2…
GLP-1 drugs appear psychiatrically safe, but one finding still raises questions
With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
Semaglutide slows blood protein signature linked to future dementia risk
In older adults with cardiovascular disease and overweight or obesity, semaglutide slowed worsening of a blood-based dementia risk…
Mouse study shows how liraglutide briefly rewires gut bacterial communities
A mouse study tracks how a leading GLP-1 drug alters gut bacteria over time, offering new clues to…
Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits
A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
Semaglutide dose may matter more than weight loss for heart health
A large real-world study suggests semaglutide’s cardiovascular benefits may be more closely linked to the dose patients receive…
Gut microbiota may shape eating behavior and guide new obesity treatments
From appetite signals to food reward, researchers reveal how gut microbes may influence disordered eating and obesity, while…
GLP-1RAs linked to lower risk of amputation in diabetes with PAD
The largest meta-analysis to date suggests GLP-1RAs may reduce major limb complications in people with type 2 diabetes…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…